Structure Therapeutics Inc.·4

Mar 18, 8:45 PM ET

Hall Ashley 4

4 · Structure Therapeutics Inc. · Filed Mar 18, 2025

Insider Transaction Report

Form 4
Period: 2025-03-15
Hall Ashley
Chief Development Officer
Transactions
  • Award

    Employee Stock Option (right to buy)

    2025-03-15+124,032124,032 total
    Exercise: $7.02Exp: 2035-03-15Ordinary Shares (124,032 underlying)
  • Award

    Ordinary Shares

    2025-03-15+51,048118,338 total
Footnotes (4)
  • [F1]The Ordinary Shares of the Issuer may be represented by American Depositary Shares ('ADSs"). Each ADS represents three Ordinary Shares of the Issuer.
  • [F2]Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one ordinary share of the Issuer. The RSUs vest 1/4th annually on each anniversary of March 1, 2025, subject to Reporting Person's continued service on such dates.
  • [F3]The option exercise price per share is equal to the fair market value per Ordinary Share on the grant date based on the trading price of the Issuer's ADSs.
  • [F4]1/4th of the shares subject to the option shall vest March 1, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service through each such vesting date.

Documents

1 file
  • 4
    form4-03182025_080311.xmlPrimary